Schedule 13G ownership disclosure

180 Life Sciences Corp.

Common Stock · CUSIP: 68236V104

Event date: 2025-12-01

Filing-level shares
1,334,538.00
Percent of class
6.9%
  • Pemble Brian James

    Shares: 1,334,538.00 · Class: 6.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002088659-25-000005
Form type
SCHEDULE 13G/A
Filer
FORUM MARKETS Inc
CIK
CIK 1690080
Filed
Dec 01, 2025
Reporting period
Dec 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub